Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES
Latest News and Updates
Sandoz Endorses A Global Campaign To Promote Biosimilars
Act4Biosimilars aims to increase patient access to novel therapies by developing biosimilars with endeavour backed by diverse steering group of care providers.
300 Drug Brands Chosen To Get QR Codes- Indian Government
To verify authenticity and enable tracing, drug pricing regulator in India has identified top 300 brands which will need to include QR codes on their packages.
Novartis Victim of Cyberattack But No Sensitive Data Leaked
The data was allegedly stolen from Novartis factory by cyber organisation Industrial Spy. The data concerns RNA and DNA-based drug testing and technologies.
Jubilant Wins $146.6 Mn Contract To Boost Injectables Output
CDMO to increase its capacity to create sterile injectables to fulfil current and future demands thanks to $146.6 million pact with Health and Human Services.
US Biotech Affinivax To Be Bought By GSK For $3.3 billion
Acquisition will help to expand coverage against common pneumococcal serotypes, which lead to high immunogenicity in contrast to currently available vaccines.
Arthritis Drugs By J&J, BMS Cut Death Risk In COVID Patients
National Institutes of Health in its study revealed that arthritis drugs by J & J, BMS lowered the mortality rate in COVID-19 patients, improving health state.
U.S. FDA Cautions of Heart Issues Post Novavax COVID Vaccine
Based on a trial conducted by Novavax on almost 30,000 individuals, four instances of heart inflammation have been detected within 20 days of taking the jab.
Pfizer Commits $120mn In COVID-19 U.S. Oral Drug Production
Pfizer will be investing $120 million to expand its largest manufacturing facility at Kalamazoo in Michigan for its oral COVID-19 antiviral named Paxlovid.